GLP-1 and Adenomyosis: What the Evidence Says (October 2026)

01 · The core answer

Can a GLP-1 help with adenomyosis?

Tirzepatide, the active ingredient in Mounjaro, is licensed for weight management in adults and for type 2 diabetes.¹ Adenomyosis is not on that list.

Some summaries suggest these drugs may ease pelvic symptoms through lower inflammation. There is no trial showing that, so it should not be treated as fact. Personal accounts from online communities are not evidence of an effect on the condition, and results differ from person to person.

02 · What to do next

The decision you are actually facing

The useful question is whether you would qualify for weight treatment in its own right. If so, it is a decision about weight, not about adenomyosis. Our guide to adenomyosis and Mounjaro goes into that overlap in more detail.

If you meet the licensed criteria, a free consultation is reviewed by a GPhC-registered prescriber, who will ask about your gynaecological history. You can see the Mounjaro pen and its prices. You can also read about our wider weight loss clinic.

Related guides: Wat is glp-1 and Trapezoid glp 1 and Ozempil glp-1.

03 · How GLP-1 medicines work

How GLP-1 medicines work

Tirzepatide activates two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹

For more technical detail, see the note on AMPK and GLP-1.

04 · Weight and adenomyosis

Weight and adenomyosis

People with adenomyosis often ask whether weight is harder to manage. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

Weight loss in itself is not a treatment for adenomyosis, and you should not expect it to shrink the womb or remove pain.

05 · Safety and new symptoms

Safety and reporting symptoms

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. Tell the prescriber about your condition and any hormonal or pain treatment you use.

If your pelvic symptoms change after starting any medicine, speak to your prescriber or doctor. You can also report a suspected side effect through the Yellow Card scheme.¹⁹ A change in symptoms is not a proven effect or a proven benefit of the medicine. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

06 · Reading online claims

How to read online claims

Forum posts and social media threads are where most of this topic lives. They describe individual experiences, not controlled evidence. Other terms you may see, such as GLP-1 agonists, describe a drug class, not a proven use in gynaecology.

Be wary of anyone offering to supply a GLP-1 medicine without a consultation or prescription, or promising specific results for pelvic pain.